Treatment of raised intraocular pressure and prevention of glaucoma

British Medical Journal

Volumn 326, Issue 7392, 2003, Pages 723-724

  Wormald, R ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EDITORIAL; GLAUCOMA; GLAUCOMA SURGERY; HEALTH ECONOMICS; HUMAN; INTRAOCULAR HYPERTENSION; LASER SURGERY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SIDE EFFECT; TRABECULOPLASTY;

EID: 0037420517     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.326.7392.723     Document Type: Editorial

References (12)

1. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Kelmer JL, Miller JP, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
2. Heijl A, Leske MC, Bengtsson Bo, Hyman L, Bengtsson B, Hussein M. for the Early Manifest Glaucoma Trial Group. Reduction of intra-ocular pressure and glaucoma progression. Results from the early manifest glaucoma trial. Arch Ophthalmol 2002;120:1268-79.
3. Eddy DM, Sanders LE, Eddy JF. The value of screening for glaucoma with tonometry. Surv Ophthcalmol 1983;28:194-205.
4. Rossetti L, Marchetti I, Orzalesi N, et al. Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol 1993;111:96-103.
5. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994;101:1651-6.
6. Jay JL, Murray SB. Early trabeculectomy versus conventional management in primary open angle glaucoma. Br J Ophthalmol 1988;72:881-9.
7. Anonymous. The advanced glaucona intervention study (AGIS): The relationship between control of intraocular pressure and visual field deterioration. The AGIS investigators. Am J Ophthalmol 2000;130:429-40.
8. Schulzer M. Intraocular pressure reduction in normal-tension glaucoma patients, the normal tension glaucoma study group. Ophthalmology 1992;99:1468-70.
9. Diggory P, Cassels-Brown A, Vail A, Abbey LM, Hillman JS. Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents. Lancet 1995;345:1604-6.
10. Kirwan JF, Nightingale LA, Bunce C, Wormald R. Glaucoma therapy and excess risk of airways obstruction: population based cohort study. BMJ 2002;325:1396-7.
11. Leske MC, Wu SY, Nemesure B, Hemnis A. Risk factors for incident nuclear opacities. Ophthalmology 2002;109:1303-8.
12. The European Glaucoma Prevention Study Group. The European glaucoma prevention study design and baseline description of participants. Ophthalmology 2002;109:1612-21.